SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report)’s stock price fell 1.2% on Tuesday. The stock traded as low as $24.38 and last traded at $24.38. Approximately 200 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Stock Down 1.2%
The firm has a market capitalization of $6.64 billion, a price-to-earnings ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81. The business’s fifty day moving average is $24.38 and its 200 day moving average is $24.38.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB, commonly known as Sobi, is a Sweden-based biopharmaceutical company focused on developing and providing treatments for rare diseases. The company’s activities primarily cover hematology, immunology, and other conditions in which patients have limited treatment options.
Sobi’s portfolio includes therapies for bleeding disorders, immune-mediated diseases, and rare inflammatory conditions. Its products and services span the development, manufacturing, commercialization, and distribution of medicines, with the company also working with external partners to bring specialized treatments to patients.
Headquartered in Stockholm, Sobi serves patients and healthcare providers internationally through operations and commercial partnerships across Europe, North America, and other markets.
Featured Stories
- Five stocks we like better than SWEDISH ORPHAN/S
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
